{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9514007", "DateCompleted": {"Year": "1998", "Month": "05", "Day": "06"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "61", "Issue": "2", "PubDate": {"Year": "1998", "Month": "Feb"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Synthesis and biological activity of esters in the trans-1,2-dihydroxy-1,2-dihydroacronycine series.", "Pagination": {"StartPage": "198", "EndPage": "201", "MedlinePgn": "198-201"}, "Abstract": {"AbstractText": ["Permanganate oxidation of acronycine (1) led to keto alcohol 4 which could be reduced to trans-1,2-dihydroxy-1,2-dihydroacronycine (3) using NaBH4. Acylation of 3 afforded 12, 13, and 14. These esters (12, 13, and 14) were more potent than 1 when tested against L-1210 cells in vitro. Diacetate 12 was evaluated in vivo against murine P-388 leukemia and was markedly active at a dose 16-fold lower than acronycine itself. Comparison of these results with those recently obtained in the cis-1,2-dihydroxy-1,2-dihydroacronycine series is discussed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Pharmacognosy, University of Athens, Greece."}], "LastName": "Magiatis", "ForeName": "P", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mitaku", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Skaltsounis", "ForeName": "A L", "Initials": "AL"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Tillequin", "ForeName": "F", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Koch", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Pierr\u00e9", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Atassi", "ForeName": "G", "Initials": "G"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "1,2-dihydroxy-1,2-dihydroacronycine"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "QE0G097358", "NameOfSubstance": "Acronine"}], "MeshHeadingList": [{"QualifierName": ["analogs & derivatives", "isolation & purification", "pharmacology"], "DescriptorName": "Acronine"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia L1210"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia P388"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "3", "Day": "26"}, {"Year": "1998", "Month": "3", "Day": "26", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "3", "Day": "26", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9514007", "10.1021/np970427s", "np970427s"]}}]}